Functional neural correlates of anosognosia in Alzheimer s disease. University Medical Center Groningen

Size: px
Start display at page:

Download "Functional neural correlates of anosognosia in Alzheimer s disease. University Medical Center Groningen"

Transcription

1 Functional neural correlates of anosognosia in Alzheimer s disease Jaime D. Mondragón M.D., M.S. Prof. Dr. Natasha M. Maurits Prof. Dr. Peter P. De Deyn April 13 th, 2018 Department of Neurology Clinical Neuroengineering Alzheimer Research Center Groningen University Medical Center Groningen

2 Outline 1. Introduction Impact Biomarkers Imaging modalities Anosognosia 2. Results Neural correlates of anosognosia Past and Future projects

3 Impact, Biomarkers, Imaging Modalities, and Anosognosia INTRODUCTION

4 Impact Alzheimer s disease Estimated worldwide cost (billions of dollars) 35,6 million worldwide (2010) 54% developing countries 60-80% of dementias World estimated prevalence 2030: 65,7 million 2050: 115,4 million Mexico 2030: 2,7 million Direct and indirect costs Jack Jr et al. (2013). Lancet Neurology; 12: Sosa-Ortiz et al. (2012). Archives of medical research; 43: Wimo et al. (2013). Alzheimer & Dementia; 9: 1-13.

5 Model of dynamic biomarkers Biological o o CSF Serum Bateman et al. (2012). N Engl J Med.; 367(9): Jack Jr et al. (2013). Lancet Neurology; 12:

6 Model of dynamic biomarkers Imaging o o Structural Functional Bateman et al. (2012). N Engl J Med.; 367(9): Jack Jr et al. (2013). Lancet Neurology; 12:

7 Multifactorial causal model Iturria-Medina et al. (2016). Nat. Commun; 7: Iturria-Medina et al. (2017). Neuroimage; 152:

8 Overview of neuroimaging modalities Grinvald and Hildesheim. (2004). Nature reviews neurosci; 5(11):

9 Anosognosia From the Greek, α = without, νόσϛ = disease, γνώσιϛ = knowledge Joseph Babinski in 1914, Revue Neurologie Dorland s medical dictionary Unawareness or denial of a neurological deficit such as hemiplegia The lack of awareness of motor, visual or cognitive deficits in patients with neurological diseases Di Perri et al. (2014). Epilepsy Behav; 30: Dorland and Newman. (2012). Dorland's illustrated medical dictionary; 32: 96. Nurmi and Jehkonen. (2014). Cortex; 61:

10

11 Anosognosia classification Subtypes or etiology: Hemiplegic, cortical blindness, Anton s syndrome, visual field defect, traumatic brain injury, multiple sclerosis, Parkinson s disease, Alzheimer s disease, mild cognitive impairment, frontotemporal dementia and Huntington s disease. Anosognosia in Alzheimer s disease Anosognosia Questionnaire-Dementia (AQ-D) Dementia Deficits Scale (DDS) Adjusted Memory Awareness Rating Scale (MARSA) Vannini et al. (2017). Neuropsychologia; 99: Nurmi and Jehkonen. (2014). Cortex; 61:

12 Neural Correlates of Anosognosia RESULTS

13 Neural correlates of anosognosia Systematic review PubMed, EMBASE and PsycINFO on March 2018 Identical research strategy with a priori variables was realized on each database following the PRISMA statement (Moher et al., 2009). Keywords: anosognosia, self-appraisal, insight, awareness, and consciousness combined with each of the following terms dementia, Alzheimer, mild cognitive impairment Supplementary search was performed using MRI, PET, SPECT, connectivity, activation, hypometabolism, and hypermetabolism. Mondragón et al. (2018). Neurosci Biobehav Rev.; in press.

14

15 Highlights Abnormal frontotemporal activity occurs in MCI and AD with anosognosia MCI patients with anosognosia (MCIwa) have reduced parietotemporal metabolism MCIwa have reduced cortical midline (CM) perfusion and activation Anosognosia in AD reduces DMN activation and within network connectivity Reduced neural activity pattern in anosognosia: CM, parietotemporal, frontotemporal Mondragón et al. (2018). Neurosci Biobehav Rev.; in press.

16 Neural correlates of anosognosia Figure 2. Graphical representation of the neural correlates in MCI patients with anosognosia. Mondragón et al. (2018). Neurosci Biobehav Rev.; in press.

17 Neural correlates of anosognosia Figure 3. Graphical representation of the neural correlates of unawareness in MCI. Mondragón et al. (2018). Neurosci Biobehav Rev.; in press.

18 Neural correlates of anosognosia Figure 4. Graphical representation of the neural correlates in mild to moderate AD patients with anosognosia. Mondragón et al. (2018). Neurosci Biobehav Rev.; in press.

19 Neural correlates of anosognosia Figure 5. Graphical representation of the neural correlates of unawareness in mild to moderate AD. Mondragón et al. (2018). Neurosci Biobehav Rev.; in press.

20 Mondragón et al. (2018). Neurosci Biobehav Rev.; in press.

21 Hippocampal volume Mondragón et al. (2016). Dement Geriatr Cogn Dis Extra; 6:

22 Hippocampal volume Mondragón et al. (2016). Dement Geriatr Cogn Dis Extra; 6:

23 Hippocampal volume Mondragón et al. (2016). Dement Geriatr Cogn Dis Extra; 6:

24 Future projects Neural correlates of anosgnosia in Alzheimer s Disease Neuroimaging Initiative Neural correlates of anosgnosia in Parelsnoer Initiative

25

Form D1: Clinician Diagnosis

Form D1: Clinician Diagnosis Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.

More information

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease

More information

Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment (MCI) October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine

More information

Anosognosia and rehabilitation: Definitions, practice implications, and directions for future research. Nicole Matichuk* and Liv Brekke **

Anosognosia and rehabilitation: Definitions, practice implications, and directions for future research. Nicole Matichuk* and Liv Brekke ** Main Article Health Professional Student Journal 2016 1(3) Anosognosia and rehabilitation: Definitions, practice implications, and directions for future research Nicole Matichuk* and Liv Brekke ** Abstract:

More information

Molecular Imaging and the Brain

Molecular Imaging and the Brain Molecular imaging technologies are playing an important role in neuroimaging, a branch of medical imaging, by providing a window into the living brain. Where CT and conventional MR imaging provide important

More information

CSF Aβ1-42 predicts cognitive impairment in de novo PD patients

CSF Aβ1-42 predicts cognitive impairment in de novo PD patients CSF Aβ1-42 predicts cognitive impairment in de novo PD patients Mark Terrelonge MPH *1, Karen Marder MD MPH 1, Daniel Weintraub MD 2, Roy Alcalay MD MS 1 1 Columbia University Department of Neurology 2

More information

USE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013

USE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013 Please visit our website for more information http://sgec.stanford.edu/ SGEC Webinar Handouts 1/18/2013 2013 WEBINAR SERIES STATE OF THE SCIENCE: DEMENTIA EVALUATION AND MANAGEMENT AMONG DIVERSE OLDER

More information

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends

More information

Imaging of Alzheimer s Disease: State of the Art

Imaging of Alzheimer s Disease: State of the Art July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression

More information

Anosognosia, or loss of insight into one s cognitive

Anosognosia, or loss of insight into one s cognitive REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and

More information

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018 Improving diagnosis of Alzheimer s disease and lewy body dementia Brain TLC October 2018 Plan for this discussion: Introduction to AD and LBD Why do we need to improve diagnosis? What progress has been

More information

Brain imaging for the diagnosis of people with suspected dementia

Brain imaging for the diagnosis of people with suspected dementia Why do we undertake brain imaging in dementia? Brain imaging for the diagnosis of people with suspected dementia Not just because guidelines tell us to! Exclude other causes for dementia Help confirm diagnosis

More information

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) A. The development of multiple cognitive deficits manifested by both 1 and 2 1 1. Memory impairment 2. One (or more) of the following

More information

Patients with disorders of consciousness: how to treat them?

Patients with disorders of consciousness: how to treat them? Patients with disorders of consciousness: how to treat them? Aurore THIBAUT PhD Student Coma Science Group LUCA meeting February 25 th 2015 Pharmacological treatments Amantadine Giacino (2012) 184 TBI

More information

An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease

An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease Angelica Quartino 1* Dan Polhamus 2*, James Rogers 2, Jin Jin 1 212, Genentech

More information

EPILESSIA Epidemiologia e inquadramento diagnostico. Ettore Beghi IRCCS Istituto Mario Negri, Milano

EPILESSIA Epidemiologia e inquadramento diagnostico. Ettore Beghi IRCCS Istituto Mario Negri, Milano EPILESSIA Epidemiologia e inquadramento diagnostico Ettore Beghi IRCCS Istituto Mario Negri, Milano Disclosures Research grants from the Italian Ministry of Health, Italian Drug Agency, American ALS Association

More information

Form A3: Subject Family History

Form A3: Subject Family History Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician

More information

SHARED CARE OF MCI/EARLY DEMENTIA

SHARED CARE OF MCI/EARLY DEMENTIA SHARED CARE OF MCI/EARLY DEMENTIA BY DR. OLUFEMI BANJO MD, DTM, DCP, DIPA&DS, DHM, M.Med.Sc, FRCP(C) GERIATRIC PSYCHIATRIST. ASSISTANT MEDICAL DIRECTOR, ADULT MENTAL HEALTH AND ADDICTION, GRAND RIVER HOSPITAL

More information

Subject Index. Berkson bias 72

Subject Index. Berkson bias 72 Subject Index AAAT study 62 Absolute risk reduction (ARR) 40 ACCORD study 62 AD, see Alzheimer s disease ADVANCE study 62 ALLHAT study 62 ALS, see Amyotrophic lateral sclerosis Alzheimer s disease (AD)

More information

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline

United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline United Council for Neurologic Subspecialties Geriatric Neurology Written Examination Content Outline REV 3/24/09 The UCNS Geriatric Neurology examination was established to determine the level of competence

More information

Update on functional brain imaging in Movement Disorders

Update on functional brain imaging in Movement Disorders Update on functional brain imaging in Movement Disorders Mario Masellis, MSc, MD, FRCPC, PhD Assistant Professor & Clinician-Scientist Sunnybrook Health Sciences Centre University of Toronto 53 rd CNSF

More information

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Dementia Update Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Nothing to disclose Dementia Progressive deterioration in mental function

More information

How can the new diagnostic criteria improve patient selection for DM therapy trials

How can the new diagnostic criteria improve patient selection for DM therapy trials How can the new diagnostic criteria improve patient selection for DM therapy trials Amsterdam, August 2015 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM)

More information

Heterogeneous Data Mining for Brain Disorder Identification. Bokai Cao 04/07/2015

Heterogeneous Data Mining for Brain Disorder Identification. Bokai Cao 04/07/2015 Heterogeneous Data Mining for Brain Disorder Identification Bokai Cao 04/07/2015 Outline Introduction Tensor Imaging Analysis Brain Network Analysis Davidson et al. Network discovery via constrained tensor

More information

Neuropsychiatric symptoms as predictors of MCI and dementia: Epidemiologic evidence

Neuropsychiatric symptoms as predictors of MCI and dementia: Epidemiologic evidence 16th Annual MCI Symposium January 20, 2018 Miami, FL Neuropsychiatric symptoms as predictors of MCI and dementia: Epidemiologic evidence Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant,

More information

Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation

Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation 1. Reflection of Mild Cognitive Impairment (MCI) and Dementias by Molecular Imaging, PET

More information

Delirium in Older Persons: An Investigative Journey

Delirium in Older Persons: An Investigative Journey Delirium in Older Persons: An Investigative Journey Sharon K. Inouye, M.D., M.P.H. Professor of Medicine Beth Israel Deaconess Medical Center Harvard Medical School Milton and Shirley F. Levy Family Chair

More information

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease What is PRESENTS DEMENTIA? WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: Memory Reasoning Planning Learning Attention Language Perception Behavior AS OF 2013 There

More information

Is PET/CT really helpful in diagnosing Alzheimer s Disease?

Is PET/CT really helpful in diagnosing Alzheimer s Disease? Is PET/CT really helpful in diagnosing Alzheimer s Disease? J. Rudolf MD Ph.D. Consultant in Neurology, Dept. of Neurology, General Hospital Papageorgiou Thessaloniki, Greece Conflict of Interest PET/CT

More information

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge Introduction, use of imaging and current guidelines John O Brien Professor of Old Age Psychiatry University of Cambridge Why do we undertake brain imaging in AD and other dementias? Exclude other causes

More information

European Prevention of Alzheimer s Dementia (EPAD)

European Prevention of Alzheimer s Dementia (EPAD) European Prevention of Alzheimer s Dementia (EPAD) Ron Marcus, MD ISCTM Adaptive Design Workshop February 20, 2018 1 EPAD Goal The European Prevention of Alzheimer's Dementia (EPAD) project aims to develop

More information

review of existing studies on ASL in dementia Marion Smits, MD PhD

review of existing studies on ASL in dementia Marion Smits, MD PhD review of existing studies on ASL in dementia Marion Smits, MD PhD Associate Professor of Neuroradiology Department of Radiology, Erasmus MC, Rotterdam (NL) Alzheimer Centre South-West Netherlands, Rotterdam

More information

The Aging Brain The Aging Brain

The Aging Brain The Aging Brain The Aging Brain The Aging Brain R. Scott Turner, MD, PhD Director, Memory Disorders Program Professor, Department of Neurology Georgetown University Washington, DC memory.georgetown.edu rst36@georgetown.edu

More information

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal

More information

Delirium & Dementia. Nicholas J. Silvestri, MD

Delirium & Dementia. Nicholas J. Silvestri, MD Delirium & Dementia Nicholas J. Silvestri, MD Outline Delirium vs. Dementia Neural pathways relating to consciousness Encephalopathy Stupor Coma Dementia Delirium vs. Dementia Delirium Abrupt onset Lasts

More information

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms State of the art lecture March 4-2012 Philippe H Robert, Philippe Nice - France Robert The diagnosis of AD Neuropsychiatric

More information

17 th WORKSHOP ON NEUROOTOLOGY. Dementia & Imbalance. DR. ATRI CHATTERJEE Assistant Professor. Neurology VMMC & SafdarJung Hospital New Delhi

17 th WORKSHOP ON NEUROOTOLOGY. Dementia & Imbalance. DR. ATRI CHATTERJEE Assistant Professor. Neurology VMMC & SafdarJung Hospital New Delhi 17 th WORKSHOP ON NEUROOTOLOGY Dementia & Imbalance DR. ATRI CHATTERJEE Assistant Professor. Neurology VMMC & SafdarJung Hospital New Delhi ?Association Dementia Imbalance?Causation balance: An even distribution

More information

Author's response to reviews

Author's response to reviews Author's response to reviews Title: MRI-negative PET-positive Temporal Lobe Epilepsy (TLE) and Mesial TLE differ with Quantitative MRI and PET: a case control study Authors: Ross P Carne (carnero@svhm.org.au)

More information

Depression: An Important Risk Factor for Cognitive Decline

Depression: An Important Risk Factor for Cognitive Decline Depression: An Important Risk Factor for Cognitive Decline No conflicts of interest Sarah K. Tighe, M.D. Assistant Professor University of Iowa Carver College of Medicine Department of Psychiatry Institute

More information

Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre

Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre Today Introduction to CT Introduction to MRI Introduction to nuclear medicine Imaging the dementias The Brain ~ 1.5

More information

HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?

HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE? EAMA CORE CURRICULUM HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE? Sofia Duque Orthogeriatric Unit São Francisco Xavier Hospital Occidental Lisbon Hospital Center University Geriatric Unit, Faculty of

More information

A U. Methods of Cognitive Neuroscience 2/8/2016. Neat Stuff! Cognitive Psychology

A U. Methods of Cognitive Neuroscience 2/8/2016. Neat Stuff! Cognitive Psychology Methods of Cognitive Neuroscience Neat Stuff! Optogenetics http://spie.org/newsroom/technical-articles-archive/videos/0411-boyden Stimulating the brain with light Cognitive Psychology Mental Representation

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Erin Cullnan Research Assistant, University of Illinois at Chicago

Erin Cullnan Research Assistant, University of Illinois at Chicago Dr. Moises Gaviria Distinguished Professor of Psychiatry, University of Illinois at Chicago Director of Consultation Liaison Service, Advocate Christ Medical Center Director of the Older Adult Program,

More information

Dementia Past, Present and Future

Dementia Past, Present and Future Dementia Past, Present and Future Morris Freedman MD, FRCPC Division of Neurology Baycrest and University of Toronto Rotman Research Institute, Baycrest CNSF 2015 Objectives By the end of this presentation,

More information

Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network

Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network Neuroimaging for dementia diagnosis Guidance from the London Dementia Clinical Network Authors Dr Stephen Orleans-Foli Consultant Psychiatrist, West London Mental Health NHS Trust Dr Jeremy Isaacs Consultant

More information

Understanding Symptoms, Causes, and Risks for Alzheimer s Disease

Understanding Symptoms, Causes, and Risks for Alzheimer s Disease Understanding Symptoms, Causes, and Risks for Alzheimer s Disease Gene E. Alexander, Ph.D., Professor of Psychology, Neuroscience, and Physiological Sciences; Director, Brain Imaging, Behavior & Aging

More information

The world is graying: Dementia is an alarming issue

The world is graying: Dementia is an alarming issue Guest Editorial Paper Sapkota et.al. N Sapkota, Fellowship (Geriatric Psychiatry) Associate Professor and Head, Department of Psychiatry B.P. Koirala Institute of Health Sciences, Dharan, Nepal The world's

More information

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease AIBL: Two site collaborative study Study is conducted at two sites: Perth

More information

This item is the archived peer-reviewed author-version of:

This item is the archived peer-reviewed author-version of: This item is the archived peer-reviewed author-version of: Severe bilateral subdural hematomas as a complication of diagnostic lumbar puncture for possible Alzheimers disease Reference: Verslegers Lieven,

More information

September 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by

September 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by September 26 28, 2013 Westin Tampa Harbour Island Co-sponsored by From Brains at Risk to Cognitive Dysfunction: The Role of Vascular Pathology Ralph Sacco, MD, MS, FAHA, FAAN Miller School of Medicine

More information

I do not have any disclosures

I do not have any disclosures Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo

More information

The Role of Cognitive Reserve in the clinical presentation of Alzheimer s Disease Dorene M. Rentz, PsyD

The Role of Cognitive Reserve in the clinical presentation of Alzheimer s Disease Dorene M. Rentz, PsyD The Role of Cognitive Reserve in the clinical presentation of Alzheimer s Disease Dorene M. Rentz, PsyD Division of Cognitive and Behavioral Neurology, Brigham and Women s Hospital Co-Director of the Center

More information

Alzheimer s Disease. Clinical characteristics of late-onset Alzheimer s disease (LOAD) A/Prof David Darby

Alzheimer s Disease. Clinical characteristics of late-onset Alzheimer s disease (LOAD) A/Prof David Darby Alzheimer s Disease Clinical characteristics of late-onset Alzheimer s disease (LOAD) A/Prof David Darby Florey Institute of Neuroscience and Mental Health 28-6-2013 The burden of late-onset Alzheimer

More information

Advances in Clinical Neuroimaging

Advances in Clinical Neuroimaging Advances in Clinical Neuroimaging Joseph I. Tracy 1, PhD, ABPP/CN; Gaelle Doucet 2, PhD; Xaiosong He 2, PhD; Dorian Pustina 2, PhD; Karol Osipowicz 2, PhD 1 Department of Radiology, Thomas Jefferson University,

More information

NACC Minimum Data Set (MDS) Public Data Element Dictionary

NACC Minimum Data Set (MDS) Public Data Element Dictionary Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu

More information

Geri R Hall, PhD, GCNS, FAAN Advanced Practice Nurse Emeritus Banner Alzheimer s Institute

Geri R Hall, PhD, GCNS, FAAN Advanced Practice Nurse Emeritus Banner Alzheimer s Institute Geri R Hall, PhD, GCNS, FAAN Advanced Practice Nurse Emeritus Banner Alzheimer s Institute Anosognosia Purpose: To introduce caregivers and health professionals to symptoms of lack of awareness and other

More information

Postdoctoral and research scientist positions

Postdoctoral and research scientist positions Postdoctoral and research scientist positions Postdoctoral Positions 1. Brain Injury in Contact Sports 2. Imaging Genetics 3. Multi-parametric Tumor Quantification 4. Deep Learning for Neuroimaging 5.

More information

Mentis Cura November

Mentis Cura November Mentis Cura November 29 2012 www.mentiscura.com New Facts on Alzheimer s Death rank nr. 2-5 in western countries Fastest growing disease in: Cost Incedence Death rate People with Alzheimer s 2012 36 million

More information

NEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES.

NEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA NEXT-Link DEMENTIA is a network of Danish

More information

Imaging in Dementia:

Imaging in Dementia: Imaging in Dementia: Options for Clinical Practice 2017 John A. Bertelson, MD Clinical Chief of Neurology, Seton Brain and Spine Institute Assistant Professor of Medicine, Dell Medical School, UT Austin

More information

Latest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice

Latest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/alzheimers-disease-towards-earlier-detection/latest-methods-earlydetection-alzheimers-cognitive-assessments-and-diagnostic-tools-practice/8321/

More information

Alzheimer s Disease Neuroimaging Initiative

Alzheimer s Disease Neuroimaging Initiative Alzheimer s Disease Neuroimaging Initiative Steering Committee Meeting April 18, 2016 Neuropathology Core John C. Morris, MD Nigel J. Cairns, PhD, FRCPath Erin Franklin, MS Table 1. Participants Autopsied

More information

SATURDAY, SEPTEMBER 16, 2017

SATURDAY, SEPTEMBER 16, 2017 Key Description Teaching Course Scientific Session: Main Topics Free Papers Plenary Lecture Regional Symposium Session Scientific Session: Topics Sponsored Symposium Tournament of the Minds Breaks Japanese

More information

The Hellenic Longitudinal Investigation of Aging and Diet (HELIAD): study description and preliminary data

The Hellenic Longitudinal Investigation of Aging and Diet (HELIAD): study description and preliminary data The Hellenic Longitudinal Investigation of Aging and Diet (HELIAD): study description and preliminary data Kalligerou F 1, Sakka P 1, Dardiotis E 2, Kosmidis M 5, Yannakoulia M 4, Hadjigeorgiou G 2, Scarmeas

More information

Disentangling Delirium and Dementia

Disentangling Delirium and Dementia Disentangling Delirium and Dementia Sharon K. Inouye, M.D., M.P.H. Professor of Medicine Beth Israel Deaconess Medical Center Harvard Medical School Milton and Shirley F. Levy Family Chair Director, Aging

More information

Regulatory Challenges across Dementia Subtypes European View

Regulatory Challenges across Dementia Subtypes European View Regulatory Challenges across Dementia Subtypes European View Population definition including Early disease at risk Endpoints in POC studies Endpoints in pivotal trials 1 Disclaimer No CoI The opinions

More information

OMICS Group. Contact us at:

OMICS Group. Contact us at: OMICS Group OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 400 leading-edge peer

More information

tdcs in Clinical Disorders

tdcs in Clinical Disorders HBM Educational course Brain Stimulation: Past, Present and Future Hamburg, June 8th, 2014 tdcs in Clinical Disorders Agnes Flöel NeuroCure Clinical Research Center, Neurology, & Center for Stroke Research

More information

The role of reality monitoring in anosognosia for hemiplegia. Christine Roffe 3 & Simon J. Ellis 5

The role of reality monitoring in anosognosia for hemiplegia. Christine Roffe 3 & Simon J. Ellis 5 Reality monitoring in AHP 1 Running Head: REALITY MONITORING IN AHP The role of reality monitoring in anosognosia for hemiplegia Paul M. Jenkinson 1*, Nicola M. J. Edelstyn 2, 3, Justine L. Drakeford 4,

More information

Detection of Mild Cognitive Impairment using Image Differences and Clinical Features

Detection of Mild Cognitive Impairment using Image Differences and Clinical Features Detection of Mild Cognitive Impairment using Image Differences and Clinical Features L I N L I S C H O O L O F C O M P U T I N G C L E M S O N U N I V E R S I T Y Copyright notice Many of the images in

More information

Changing diagnostic criteria for AD - Impact on Clinical trials

Changing diagnostic criteria for AD - Impact on Clinical trials Changing diagnostic criteria for AD - Impact on Clinical trials London, November 2014 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM) Salpêtrière Hospital

More information

Research and possible future brain health treatments

Research and possible future brain health treatments Research and possible future brain health treatments Cheryl Brandi, DNSc, ARNP, NP-C Roskamp Institute Clinic July 21, 2016 brandi, roskamp institute 1 The Roskamp Institute Not for profit biomedical research

More information

Multimodal Imaging in Extratemporal Epilepsy Surgery

Multimodal Imaging in Extratemporal Epilepsy Surgery Open Access Case Report DOI: 10.7759/cureus.2338 Multimodal Imaging in Extratemporal Epilepsy Surgery Christian Vollmar 1, Aurelia Peraud 2, Soheyl Noachtar 1 1. Epilepsy Center, Dept. of Neurology, University

More information

Type 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky

Type 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky Type 2 Diabetes and Brain Disease in Older Adults Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky Disclosures to Participants Requirements for Successful Completion: For successful completion,

More information

Computational and visual analysis of brain data

Computational and visual analysis of brain data Scientific Visualization and Computer Graphics University of Groningen Computational and visual analysis of brain data Jos Roerdink Johann Bernoulli Institute for Mathematics and Computer Science, University

More information

Recommendations for the Diagnosis and Treatment of Dementia 2012

Recommendations for the Diagnosis and Treatment of Dementia 2012 Recommendations for the Diagnosis and Treatment of Dementia 2012 Based on the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (4 th CCCDTD) 2012 Gauthier S, Patterson C, Chertkow

More information

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion Alzheimer s and Dementia Research: An Advanced Discussion Brad Boeve, MD Department of Neurology Mayo Clinic Alzheimer s and Dementia Research: An Advanced Discussion Theoretical Constructs in Aging/Dementia

More information

Assessing and Managing the Patient with Cognitive Decline

Assessing and Managing the Patient with Cognitive Decline Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor

More information

Mild Cognitive Impairment

Mild Cognitive Impairment Mild Cognitive Impairment Victor W. Henderson, MD, MS Departments of Health Research & Policy (Epidemiology) and of Neurology & Neurological Sciences Stanford University Director, Stanford Alzheimer s

More information

Alzheimer s Disease without Dementia

Alzheimer s Disease without Dementia Alzheimer s Disease without Dementia Dr Emer MacSweeney CEO & Consultant Neuroradiologist Re:Cognition Health London Osteopathic Society 13 September 2016 Early diagnosis of Alzheimer s Disease How and

More information

TGF-ß1 pathway as a new pharmacological target for neuroprotection in AD. Filippo Caraci

TGF-ß1 pathway as a new pharmacological target for neuroprotection in AD. Filippo Caraci Department of Clinical and Molecular Biomedicine Section of Pharmacology and Biochemistry Department of Educational Sciences University of Catania TGF-ß1 pathway as a new pharmacological target for neuroprotection

More information

Personal Reflections on the Design and Delivery of Services to Those with Cognitive Disorders

Personal Reflections on the Design and Delivery of Services to Those with Cognitive Disorders Personal Reflections on the Design and Delivery of Services to Those with Cognitive Disorders Dr. David B. Hogan Brenda Strafford Foundation Chair in Geriatric Medicine University of Calgary None to declare

More information

Recent publications using the NACC Database. Lilah Besser

Recent publications using the NACC Database. Lilah Besser Recent publications using the NACC Database Lilah Besser Data requests and publications Using NACC data Number of requests by year Type 2009 2010 2011 2012 2013 2014 2015 Data files* 55 85 217 174 204

More information

Concept paper on no need for revision of the guideline on medicinal products for the treatment of Alzheimer's disease and other dementias

Concept paper on no need for revision of the guideline on medicinal products for the treatment of Alzheimer's disease and other dementias 15 March 20122 EMA/CHMP/60715/2012 Committee for Medicinal Products for Human Use (CHMP) Concept paper on no need for revision of the guideline on medicinal products for the treatment of Alzheimer's disease

More information

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease The current state of healthcare for Normal Aging, g, Mild Cognitive Impairment, & Alzheimer s Disease William Rodman Shankle, MS MD FACP Director, Alzheimer s Program, Hoag Neurosciences Institute Neurologist,

More information

3 COMMON PSYCHIATRIC DISORDERS IN OLDER ADULTS: NEW INSIGHTS

3 COMMON PSYCHIATRIC DISORDERS IN OLDER ADULTS: NEW INSIGHTS 3 COMMON PSYCHIATRIC DISORDERS IN OLDER ADULTS: NEW INSIGHTS PHOVOIR/SHUTTERSTOCK Mild cognitive impairment (MCI), dementia, and depression are common in elderly patients. Three new studies focus on the

More information

Assessing Cognition. Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin

Assessing Cognition. Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin Assessing Cognition Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin Agenda Topic: Cognitive Aging Assessing Cognition Diagnosing Cognitive Impairment Dementia Diagnoses Symptoms

More information

Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators

Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators ASPREE Randomized, double-blind, placebo-controlled trial for extending healthy

More information

Evaluations. Alzheimer s Disease A Public Health Response. Viewer Call-In. July 19, Guest Speakers. Thanks to our Sponsors:

Evaluations. Alzheimer s Disease A Public Health Response.   Viewer Call-In. July 19, Guest Speakers. Thanks to our Sponsors: Alzheimer s Disease A Public Health Response July 19, 2007 1 2 Guest Speakers Thanks to our Sponsors: Earl A. Zimmerman, M.D. Bender Endowed Chair of Neurology and Director of the Alzheimer s Center at

More information

Claims & Underwriting. You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association

Claims & Underwriting. You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association Claims & Underwriting Alzheimer s & Cognitive Impairment: You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association 1 OVERVIEW Impact

More information

Engineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos,

Engineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos, Engineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos, Susan Resnik, Sterling Johnson, and Pierre Jedynak Longitudinal

More information

The added value of the IWG-2 diagnostic criteria for Alzheimer s disease

The added value of the IWG-2 diagnostic criteria for Alzheimer s disease The added value of the IWG-2 diagnostic criteria for Alzheimer s disease Miami, January 2016 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM) Salpêtrière

More information

Advances in Alzheimer s diagnosis; implications for clinical practice. Wiesje M. van der Flier Alzheimer Europe Conference Berlin, 4 October 2017

Advances in Alzheimer s diagnosis; implications for clinical practice. Wiesje M. van der Flier Alzheimer Europe Conference Berlin, 4 October 2017 Advances in Alzheimer s diagnosis; implications for clinical practice Wiesje M. van der Flier Alzheimer Europe Conference Berlin, 4 October 2017 Grand Challenge Alzheimer s disease 47 million worldwide

More information

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Moving Targets: An Update on Diagnosing Dementia in the Clinic Moving Targets: An Update on Diagnosing Dementia in the Clinic Eric McDade DO Department of Neurology School of Medicine Alzheimer Disease Research Center Disclosures No relevant financial disclosures

More information

Il processo diagnostico dell Alzheimer dalla clinica al neuroimaging Giovanni B. Frisoni M.D.

Il processo diagnostico dell Alzheimer dalla clinica al neuroimaging Giovanni B. Frisoni M.D. Il processo diagnostico dell Alzheimer dalla clinica al neuroimaging Giovanni B. Frisoni M.D. Professor of Clinical Neurosciences, University of Geneva Médecin Responsable, Memory Clinic, Hôpitaux Universitaires

More information

Neuroscience of Consciousness II

Neuroscience of Consciousness II 1 C83MAB: Mind and Brain Neuroscience of Consciousness II Tobias Bast, School of Psychology, University of Nottingham 2 Consciousness State of consciousness - Being awake/alert/attentive/responsive Contents

More information

ANOSOGNOSIA FOR HEMIPLEGIA. Theoretical, Clinical, and Neural Aspects AHP: THEORETICAL, CLINICAL, AND NEURAL ASPECTS 1

ANOSOGNOSIA FOR HEMIPLEGIA. Theoretical, Clinical, and Neural Aspects AHP: THEORETICAL, CLINICAL, AND NEURAL ASPECTS 1 AHP: THEORETICAL, CLINICAL, AND NEURAL ASPECTS 1 ANOSOGNOSIA FOR HEMIPLEGIA Theoretical, Clinical, and Neural Aspects Bachelor Degree Project in Cognitive Neuroscience 15 ECTS Spring term 2011 Joel Gerafi

More information

FDG-PET e parkinsonismi

FDG-PET e parkinsonismi Parkinsonismi FDG-PET e parkinsonismi Valentina Berti Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Sez. Medicina Nucleare Università degli Studi di Firenze History 140 PubMed: FDG AND parkinsonism

More information

JOURNAL RANKING 2014 FOR BEHAVIORAL SCIENCES

JOURNAL RANKING 2014 FOR BEHAVIORAL SCIENCES The data source used is Journal Citation Reports (JCR) published by Thomson Reuters. Data generated from JCR Science Edition 2014. Behavioral Sciences covers resources dealing with the biological correlates

More information